About us
Founded in 2017, GenFleet Therapeutics Inc. is a China-based R&D biotech company pursuing innovative therapeutic molecules–small and large. We focus on developing cutting-edge products, which potentially serve as globe-wise front runners among "first-in-class" therapeutics with novel mechanism of actions. To achieve this goal, we are leveraging China's local advantages with a global prospective for new drug research and development...
Learn more
The immune system is an important component of the tumor microenvironment, and acting on the immune system has been proven an appealing and effective new cancer treatment strategy which can induce more durable responses in an increasing number of malignancies compared to chemotherapy...
Learn more
Home | About us | R&D | Careers | Media | Contact us
Copyright GenFleet Therapeutics (Shanghai) Inc. Hu ICP prepare 18006424 number